AtriCure obtained FDA clearance for the company’s AtriClip PRO2 Left Atrial Appendage (LAA) Exclusion System. The tool is used to resect the LAA during the open procedures.
The device can be used with either the left or right hand, helping to improve ease of access to the relevant anatomy. The easily accessible levers control the articulation even while the distal end is inside the patient.
It features a hoopless end effector that keeps the visual field clearer for easier application of the clip and for removal of the device once the clip is deployed.
Here’s animation showing LAA occlusion using the AtriClip PRO2 in preparation for an aortic valve replacement:
Product page: AtriClip PRO2…
Via: AtriCure…